Revised SPC: Brinavess (vernakalant) 20 mg/ml concentrate for solution for infusion

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
31 October 2019

Abstract

SPC revised to state that for patients > 113 kg, a fixed dose of vernakalant is recommended. Initial dose is 339 mg; if conversion to sinus rhythm does not occur within 15 minutes after the end of initial infusion, 226 mg may be administered.